About Index Trending news
Analyze
Top 50 Pricing
Galena Biopharma

Galena Biopharma

Work at Galena Biopharma? Add yourself to this profile

Galena Biopharma

Galena Biopharma is a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments to advance cancer care.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Post-IPO debt
$24,000,000
Employees

Unknown size

Locations
HQ
The Motley Fool

These 2 Catalysts Helped Push Galena Biopharma, Inc. 31% Higher in May

The Motley Fool

Why Galena Biopharma, Inc. Was on the Fast Track to a Higher Stock Price Today

The Motley Fool

The Single Reason Why Galena Biopharma, Inc. Rallied 67% in March

Health Stock markets
The Motley Fool

Why Galena Biopharma Inc PRESENTed a Higher Stock Price

The Motley Fool

Galena Biopharma Gives Shareholders 3 More Reasons to Bury Their Heads in the Sand --

The Motley Fool

3 Things Galena Biopharma Inc. Wants You to Know --

Health Stock markets Earnings
The Motley Fool

Galena Biopharma's 3rd-Quarter Report Is Nothing Short of Bizarre --

Health Stock markets
The Motley Fool

Here's Why Galena Biopharma's Stock Tanked Today --

The Motley Fool

4 Questions to Ask Ahead of Galena Biopharma's Third-Quarter Earnings Report --

Stock markets Health Earnings